Related references
Note: Only part of the references are listed.The Effects of Italian Mediterranean Organic Diet (IMOD) on Health Status
A. De Lorenzo et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Dietary Intake of Eicosapentaenoic and Docosahexaenoic Acid and Diabetic Nephropathy: Cohort Analysis of the Diabetes Control and Complications Trial
Cheetin C. Lee et al.
DIABETES CARE (2010)
Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with Type 2 diabetes mellitus
C. -Y. Wong et al.
DIABETIC MEDICINE (2010)
The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials
Edgar R. Miller et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Effects of Fat and Fatty Acid Intake on Inflammatory and Immune Responses: A Critical Review
Claudio Galli et al.
ANNALS OF NUTRITION AND METABOLISM (2009)
Decreased activity of desaturase 5 in association with obesity and insulin resistance aggravates declining long-chain n-3 fatty acid status in Cree undergoing dietary transition
Yuan E. Zhou et al.
BRITISH JOURNAL OF NUTRITION (2009)
Omega-6 Fatty Acids and Risk for Cardiovascular Disease A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention
William S. Harris et al.
CIRCULATION (2009)
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats
Jeffrey J. Olearczyk et al.
CLINICAL SCIENCE (2009)
Emerging roles for eicosanoids in renal diseases
Niels O. S. Camara et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2009)
Arachidonic acid cytochrome P450 epoxygenase pathway
Arthur A. Spector
JOURNAL OF LIPID RESEARCH (2009)
Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice
Young-Ah Moon et al.
JOURNAL OF LIPID RESEARCH (2009)
Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial
Pietro Manuel Ferraro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans
J. Thomas Brenna et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2009)
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney
Won Suk An et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Omega-3 fatty acid rich diet prevents diabetic renal disease
Joseph H. Garman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Cross-sectional Association Between Fish Consumption and Albuminuria: The European Prospective Investigation of Cancer-Norfolk Study
Chee-Tin Christine Lee et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases
James P. Hardwick
BIOCHEMICAL PHARMACOLOGY (2008)
Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective
Pierre Singer et al.
INTENSIVE CARE MEDICINE (2008)
Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans:: CYP4F3B is the prominent player in PUFA metabolism
Maude Fer et al.
JOURNAL OF LIPID RESEARCH (2008)
n-3 fatty acids: Food or supplements?
Penny M. Kris-Etherton et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2008)
Signaling pathways modulated by fish oil in salt-sensitive hypertension
Montserrat M. Diaz Encarnacion et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Nutrition recommendations and interventions for diabetes - A position statement of the American Diabetes Association
DIABETES CARE (2008)
The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK α channel subunit in rodents
Hantz C. Hercule et al.
EXPERIMENTAL PHYSIOLOGY (2007)
Immunomodulation by omega-3 fatty acids
Philip C. Calder
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2007)
Physiologic and pathophysiologic roles of lipid mediators in the kidney
C-M Hao et al.
KIDNEY INTERNATIONAL (2007)
n-3 fatty acids in the treatment of diabetic patients - Biological rationale and clinical data
Raffaele De Caterina et al.
DIABETES CARE (2007)
Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKAy/Ta mice:: involvement of anti-inflammation and antioxidative stress
Minfang Zhang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Resolvin D series and Protectin D1 mitigate acute kidney injury
Jeremy S. Duffield et al.
JOURNAL OF IMMUNOLOGY (2006)
Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes
Gregory Proctor et al.
DIABETES (2006)
N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination
Miroslav Zeman et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2006)
Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids
Linda Schaeffer et al.
HUMAN MOLECULAR GENETICS (2006)
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
L Hooper et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice:: Involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation
S Hagiwara et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Review of the effects of omega-3 supplementation in dialysis patients
Allon Friedman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Lipoxin A4 modifies platelet-derived growth factor-induced profibrotic gene expression in human renal mesangial cells
K Rodgers et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes
ZW Wang et al.
DIABETES (2005)
EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells:: Evidence for a PPAR-γ-dependent mechanism
H Li et al.
KIDNEY INTERNATIONAL (2005)
Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage
J Theuer et al.
KIDNEY INTERNATIONAL (2005)
The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy
JV Donadio et al.
SEMINARS IN NEPHROLOGY (2004)
Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective
JT Lane
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
α-linolenic acid metabolism in men and women:: nutritional and biological implications
G Burdge
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2004)
Oxidized omega-3 fatty acids inhibit pro-inflammatory responses in glomerular endothelial cells
A Chaudhary et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2004)
Fish and long-chain ω-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women
FB Hu et al.
CIRCULATION (2003)
Fatty acid composition of serum lipid fractions in type 2 diabetic patients with microalbuminuria
MS Perassolo et al.
DIABETES CARE (2003)
Kidney CYP450 enzymes: Biological actions beyond drug metabolism
X Zhao et al.
CURRENT DRUG METABOLISM (2003)
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
PM Kris-Etherton et al.
CIRCULATION (2002)
Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials
JM Geleijnse et al.
JOURNAL OF HYPERTENSION (2002)
Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators
B Lauterbach et al.
HYPERTENSION (2002)
Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients
AV Möllsten et al.
DIABETES CARE (2001)